Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility

PurposeCrystallization of drugs formulated in the amorphous form may lead to reduced apparent solubility, decreased rate of dissolution and bioavailability and compromise the physical integrity of the solid dosage form. The purpose of this work was to develop thermodynamic approaches, both practical and theoretical, that will yield a better understanding of which factors are most important for determining the ability of polymers to stabilize amorphous active pharmaceutical ingredients (API).Materials and MethodsLattice based solution models were used to examine miscibility criteria in API-polymer blends. Different methods were used to estimate the Flory‐Huggins interaction parameter for model API-polymer systems consisting of felodipine or nifedipine with poly(vinylpyrrolidone) (PVP). These were melting point depression and determination of solubility parameters using group contribution theory. The temperature and enthalpy of fusion of crystalline API alone and the fusion temperature of the API in the presence of the polymer were measured by differential scanning calorimetry. The resultant thermal data were used to estimate the reduced driving force for crystallization and the solubility of the API in the polymer.ResultsFlory‐Huggins theory predicts that, for typical API-polymer systems, the entropy of mixing is always favorable and should be relatively constant. Due to the favorable entropy of mixing, miscibility can still be achieved in systems with a certain extent of unfavorable enthalpic interactions. For the model systems, interaction parameters derived from melting point depression were negative indicating that mixing was exothermic. Using these interaction parameters and Flory‐Huggins theory, miscibility was predicted for all compositions, in agreement with experimental data. A model was developed to estimate the solubility of the API in the polymer. The estimated solubility of the model APIs in PVP is low suggesting that kinetic rather than thermodynamic stabilization plays a significant role in inhibiting crystallization.ConclusionsThe thermodynamics of API-polymer systems can be modeled using solution based theories. Such models can contribute towards providing an understanding of the compatibility between API and polymer and the mechanisms of physical stabilization in such systems.

[1]  M. Pikal,et al.  A Spectroscopic Investigation of Hydrogen Bond Patterns in Crystalline and Amorphous Phases in Dihydropyridine Calcium Channel Blockers , 2002, Pharmaceutical Research.

[2]  Samuel H. Yalkowsky,et al.  Solubility and Solubilization in Aqueous Media , 1999 .

[3]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[4]  G. Zografi,et al.  The Effect of Low Concentrations of Molecularly Dispersed Poly(Vinylpyrrolidone) on Indomethacin Crystallization from the Amorphous State , 2003, Pharmaceutical Research.

[5]  G. Verreck,et al.  Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[7]  T. B. Grimley High-polymer solutions , 1952, Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences.

[8]  Shigeo Kojima,et al.  Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. , 2004, Journal of pharmaceutical sciences.

[9]  Yoshio Hoei,et al.  A lattice treatment of crystalline solvent-amorphous polymer mixtures on melting point depression , 1992 .

[10]  V. Tantishaiyakul,et al.  Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. , 1996, International journal of pharmaceutics.

[11]  G Zografi,et al.  Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. , 2001, Journal of pharmaceutical sciences.

[12]  J. Breitenbach Melt extrusion: from process to drug delivery technology. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  Xiaoling Li,et al.  A novel method for determination of drug solubility in polymeric matrices. , 2004, Journal of pharmaceutical sciences.

[14]  C. Anastasiadou,et al.  Solid Dispersions: Comparison of Prepared Melts and Coprecipitates of Diazepam and Polyoxyethylene Glycol 4000 , 1983 .

[15]  Patrick J. Marsac,et al.  A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems , 2006, Pharmaceutical Research.

[16]  P. Painter,et al.  Effect of hydrogen bonding on the enthalpy of mixing and the composition dependence of the glass transition temperature in polymer blends , 1991 .

[17]  J. Dressman,et al.  Thermal Properties of Hot-Stage Extrudates of Itraconazole and Eudragit E100. Phase separation and polymorphism , 2002 .

[18]  U. Griesser,et al.  Physicochemical properties of the binary system glibenclamide and polyethylene glycol 4000 , 2004 .

[19]  D. Law,et al.  Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. , 2004, Journal of pharmaceutical sciences.

[20]  P. Painter,et al.  Specific interactions and miscibility of polymer blends , 1995 .

[21]  L. S. Taylor,et al.  A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug. , 2001, International journal of pharmaceutics.

[22]  J. Sarasua,et al.  Miscibility and Specific Interactions in Blends of Poly(l-Lactide) with Poly(Vinylphenol) , 2005 .

[23]  T. Rades,et al.  Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. , 2001, International journal of pharmaceutics.

[24]  H. Sunada,et al.  Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. , 1998, Chemical & pharmaceutical bulletin.

[25]  C. Bawn,et al.  High polymer solutions. Part I.—Vapour pressure of polystyrene solutions , 1950 .

[26]  Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. , 1996 .

[27]  W R Porter,et al.  Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. , 2001, Journal of pharmaceutical sciences.

[28]  M. Newing Thermodynamic studies of silicones in benzene solution , 1950 .

[29]  R. Kaur,et al.  Comparison of polyethylene glycol and polyoxyethylene stearate as excipients for solid dispersion systems of griseofulvin and tolbutamide I: phase equilibria. , 1980, Journal of pharmaceutical sciences.

[30]  P Augustijns,et al.  Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  A. Ravve,et al.  Principles of Polymer Chemistry , 1995 .

[32]  R. F. Fedors,et al.  A method for estimating both the solubility parameters and molar volumes of liquids , 1974 .

[33]  Toshio Nishi,et al.  Melting Point Depression and Kinetic Effects of Cooling on Crystallization in Poly(vinylidene fluoride)-Poly(methyl methacrylate) Mixtures , 1975 .

[34]  E. Squillante,et al.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. , 2004, International journal of pharmaceutics.

[35]  S. Clas,et al.  Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. , 2000, Journal of pharmaceutical sciences.

[36]  J. Hoffman Thermodynamic Driving Force in Nucleation and Growth Processes , 1958 .

[37]  Peter York,et al.  The use of solubility parameters in pharmaceutical dosage form design , 1997 .

[38]  P York,et al.  Solubility parameters as predictors of miscibility in solid dispersions. , 1999, Journal of pharmaceutical sciences.